Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03901534 · ClinicalTrials.gov registry record · NA
Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD
A NA study, sponsored by Columbia University.
- Terminated
- Registry status
- NA
- Development phase
- 2,021
- Enrollment target
NCT03901534: Clinical Trial NA study, sponsored by Columbia University.
NCT03901534 is a NA study that was terminated before completion, run by Columbia University. The registered enrollment target is 2,021 participants, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03901534, a NA study, was terminated before completion, sponsored by Columbia University.
- TERMINATED
- Registry status
- NA
- Development phase
- 2,021 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether biomarkers of lung epithelial and endothelial injury are associated with obstructive sleep apnea (OSA) and interstitial lung disease (ILD).
Primary Outcome
SP-D is a marker of alveolar epithelial cell injury. This Outcome is specific to Aim 1 and will only be measured on participants in the Aim 1 phase of the study.
Interventions
- DEVICE Continuous positive airway pressure (CPAP) therapy
- DEVICE Nox A1 Recorder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,021 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2023-10-16 |
| Phase | NA |
Why NCT03901534 stopped before completion
NCT03901534 is an interventional study that assigns participants to a tested intervention. Its 2,021 participants enrollment target places it among the larger protocols in the corpus, above the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (44% higher).
The record links to 0 conditions, and to 2 interventions - of which Continuous positive airway pressure (CPAP) therapy is the first listed.
NCT03901534 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03901534 about?
NCT03901534 is a clinical study titled "Assessment of Continuous Positive Airway Pressure Therapy in OSA and ILD". The purpose of this study is to evaluate whether biomarkers of lung epithelial and endothelial injury are associated with obstructive sleep apnea (OSA) and interstitial lung disease (ILD).
What is the current status of trial NCT03901534?
This trial is currently terminated. It is a NA study. The enrollment target is 2,021 participants. The study started on 2023-01-01. Estimated completion is 2023-10-16.
What interventions are being tested in trial NCT03901534?
The interventions under investigation include: Continuous positive airway pressure (CPAP) therapy (DEVICE), Nox A1 Recorder (DEVICE).
Who is sponsoring clinical trial NCT03901534?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03901534's enrollment target sits among peer trials
2,021 52nd of 2000 higher than 1,949 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05059444 · 2,020 participants
ORACLE: Observation of ResiduAl Cancer With Liquid Biopsy Evaluation
- NCT04216732 · 2,030 participants
Natural History of Medullary Thyroid Cancer to Inform Advanced Disease Management
- NCT05625659 · 2,032 participants · NA
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
- NCT04604509 · 2,010 participants · Phase 4
Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI